Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Mitochondrial intracrines may influence ROS and apoptosis in cardiovascular disease; leaves open their therapeutic potential.
In recent years the actions of intracellular-acting, extracellular signaling proteins/peptides (intracrines) have become increasingly defined. General principles of intracrine action have been proposed. Mitochondria represent one locus of intracrine action, and thus far, angiotensin II, transforming growth factor-beta, growth hormone, atrial natriuretic peptide, Wnt 13, stanniocalcin, other renin-angiotensin system components, and vascular endothelial-derived growth factor, among others, have been shown to be mitochondria-localizing intracrines. The implications of this mitochondrial intracrine biology are discussed.
No takes yet. Share an insight, caveat, or question.
Ré et al. (2010) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: